Characterization and treatment outcomes of biologic therapy in super-responders and biologic-refractory psoriasis patients: A single-center retrospective study in China
Published: 6 January 2025| Version 1 | DOI: 10.17632/zjbcgr927x.1
Contributors:
yizhang liu, Kun Hu, Yongfang Duan, Xiang Chen, Mi Zhang, yehong kuangDescription
Supplementary Figure 1 illustrates the inclusion and exclusion criteria for psoriasis patients in this study. The univariable logistic regression analyses of patient characteristics associated with super-responders, as compared to non-super-responders, are presented in Supplementary Table 1. The results of univariable logistic regression analyses of patient characteristics associated with biologic-refractory patients, in comparison to non-biologic-refractory patients, are provided in Supplementary Table 2.
Files
Institutions
Xiangya Hospital Central South University
Categories
Biologic Agent, Psoriasis
Funding
Ministry of Science and Technology of the People's Republic of China
2023YFC2508105
National Natural Science Foundation of China
82373484, 82073447, 82003354, 82221002, 82130090, 82003362